We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+33.77%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$513M
AUM Growth
+$106M
Cap. Flow
+$6.06M
Cap. Flow %
1.18%
Top 10 Hldgs %
81.27%
Holding
82
New
6
Increased
9
Reduced
1
Closed
10
Avg Time Held
2.9 years
Top 10 Avg Time Held
1.9 years
Top 20 Avg Time Held
2.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 38.18%
2 Industrials 24.41%
3 Healthcare 15.1%
4 Materials 7.8%
5 Financials 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VENU icon
26
Venu Holding Corp
VENU
$65.6M
$2.56M 0.5%
+200,000
New +$2.69M
2025 Q3
0 quarters
OWLT icon
27
Owlet
OWLT
$130M
$2.29M 0.45%
270,000
– –
2024 Q3
4 quarters
CRIS icon
28
Curis
CRIS
$1.22M
$1.89M 0.37%
56,783
+5,000
+10% +$173K
2020 Q4
19 quarters
IMMX icon
29
Immix Biopharma
IMMX
$726M
$1.78M 0.35%
850,000
– –
2024 Q1
6 quarters
MODD icon
30
Modular Medical
MODD
$19.7M
$1.41M 0.27%
67,153
+8,681
+15% +$187K
2024 Q1
6 quarters
LLYVK icon
31
Liberty Live Group Series C
LLYVK
$9.18B
$1.34M 0.26%
13,802
– –
2023 Q3
8 quarters
CMPOW icon
32
DELISTED
CompoSecure Inc Warrant
CMPOW
$1.28M 0.25%
100,000
– –
2022 Q1
14 quarters
IRD icon
33
Opus Genetics
IRD
$334M
$1.22M 0.24%
736,842
– –
2025 Q1
2 quarters
RTX icon
34
RTX Corp
RTX
$251B
$1M 0.2%
6,000
– –
2020 Q2
21 quarters
FEAM icon
35
5E Advanced Materials
FEAM
$130M
$997K 0.19%
+285,714
New +$1.09M
2025 Q3
0 quarters
POCI icon
36
Precision Optics
POCI
$47.4M
$958K 0.19%
220,230
– –
2024 Q3
4 quarters
PROF icon
37
Profound Medical
PROF
$232M
$896K 0.17%
183,333
– –
2023 Q4
7 quarters
TLPH icon
38
Talphera
TLPH
$55.5M
$787K 0.15%
881,166
+454,545
+107% +$264K
2025 Q1
2 quarters
EVOK icon
39
DELISTED
Evoke Pharma
EVOK
$728K 0.14%
146,395
+77,645
+113% +$385K
2024 Q1
6 quarters
RNXT icon
40
RenovoRx
RNXT
$54.6M
$684K 0.13%
538,621
+38,621
+8% +$45.9K
2025 Q1
2 quarters
IPWR icon
41
Ideal Power
IPWR
$53.7M
$668K 0.13%
133,000
– –
2024 Q1
6 quarters
ICCC icon
42
ImmuCell
ICCC
$97.9M
$635K 0.12%
101,594
– –
2021 Q2
17 quarters
LLYVA icon
43
Liberty Live Group Series A
LLYVA
$8.88B
$570K 0.11%
6,047
– –
2023 Q3
8 quarters
OPFI.WS icon
44
DELISTED
OppFi Inc Warrants
OPFI.WS
$563K 0.11%
250,000
– –
2021 Q3
16 quarters
CLRB icon
45
Cellectar Biosciences
CLRB
$11.3M
$560K 0.11%
+100,000
New +$495K
2025 Q3
0 quarters
GPCR icon
46
Structure Therapeutics
GPCR
$1.58B
$560K 0.11%
20,000
+10,000
+100% +$199K
2023 Q4
7 quarters
AZ icon
47
A2Z Smart Technologies
AZ
$254M
$495K 0.1%
+62,000
New +$588K
2025 Q3
0 quarters
LHX icon
48
L3Harris
LHX
$44.9B
$489K 0.1%
1,600
– –
2019 Q4
23 quarters
MSAI icon
49
MultiSensor AI
MSAI
$9.4M
$452K 0.09%
17,500
– –
2024 Q2
5 quarters
PHYS icon
50
Sprott Physical Gold
PHYS
$15B
$371K 0.07%
12,540
– –
2019 Q4
23 quarters

Similar funds

Bleichroeder LP's Q3 2025 Portfolio in Review

As of Q3 2025, Bleichroeder LP held 82 positions worth $513M, up 26% from $407M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

Bleichroeder LP's Q3 2025 filing shows 6 new, 9 increased, 1 reduced and 10 closed positions. Its largest new stake was Fluent: 1,428,571 shares worth $3.17M. The largest sale was Alpha Cognition, an estimated $1.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 38% of assets, down from 41% a quarter earlier, followed by Industrials and Healthcare.

  • Bleichroeder LP's largest Q3 2025 buy was Fluent: 1,428,571 shares worth $3.17M.
  • Bleichroeder LP added most to Invesco QQQ Trust in Q3 2025, an estimated $1.28M increase.
  • Bleichroeder LP's biggest Q3 2025 reduction was Linde, cutting an estimated $994K.
  • Bleichroeder LP fully exited Alpha Cognition in Q3 2025, selling an estimated $1.3M.
  • Bleichroeder LP's ten largest holdings make up 81% of its $513M portfolio in Q3 2025.
  • Bleichroeder LP opened 6 new positions and closed 10 in Q3 2025.
  • Bleichroeder LP's portfolio value rose 26% quarter-over-quarter to $513M.

Based on Bleichroeder LP's 13F filing for Q3 2025, filed 14 Nov 2025.